E-mail a Wiley Online Library Link

L. Puig Dose escalation may be effective in patients with psoriasis after treatment failure or suboptimal response, but switching to adalimumab is the most cost-effective measure in different scenarios British Journal of Dermatology 168

Version of Record online: 28 FEB 2013 | DOI: 10.1111/bjd.12023

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field